(Q30251567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Treatment of Helicobacter pylori infection: Where are we now? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

Helicobacter pylori infectious disease

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Ming-Shiang Wu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Jaw-Town Lin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

1 December 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

1918-1926

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pyloriInfection

2 April 2020

cites work

1 reference

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

21 January 2018

1 reference

H. pylori and gastric cancer: the Asian enigma

21 January 2018

1 reference

Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease

21 January 2018

1 reference

The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.

21 January 2018

1 reference

A new approach for elimination of gastric cancer deaths in Japan

21 January 2018

1 reference

New concepts of resistance in the treatment of Helicobacter pylori infections

21 January 2018

1 reference

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.

21 January 2018

1 reference

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study

21 January 2018

1 reference

Optimal therapy for Helicobacter pylori infections

21 January 2018

1 reference

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

21 January 2018

1 reference

Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection

21 January 2018

1 reference

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

21 January 2018

1 reference

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

21 January 2018

1 reference

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

21 January 2018

1 reference

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

21 January 2018

1 reference

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

21 January 2018

1 reference

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

21 January 2018

1 reference

Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'.

21 January 2018

1 reference

Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection

21 January 2018

1 reference

Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.

21 January 2018

1 reference

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

21 January 2018

1 reference

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

21 January 2018

1 reference

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection

21 January 2018

1 reference

"Rescue" regimens after Helicobacter pylori treatment failure

21 January 2018

1 reference

Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.

21 January 2018

1 reference

Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance

21 January 2018

1 reference

Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy

21 January 2018

1 reference

Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment

21 January 2018

1 reference

Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial

21 January 2018

1 reference

Role of bismuth in improving Helicobacter pylori eradication with triple therapy

21 January 2018

1 reference

Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy

21 January 2018

1 reference

Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen

21 January 2018

1 reference

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

21 January 2018

1 reference

Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial.

21 January 2018

1 reference

Evidence-based recommendations for successful Helicobacter pylori treatment

21 January 2018

1 reference

Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype

21 January 2018

1 reference

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection

21 January 2018

1 reference

Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.13418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27088632%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference